YANCHENG, JIANGSU, CHILE, January 7, 2026 /EINPresswire.com/ -- In the face of increasingly demanding industrial and ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

The 2025 USA Rice Outlook Conference featured a discussion on the OBBBA, highlighting its impact on conservation and crop ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

There are institutions whose decline happens so gradually that, one day, the public simply wakes up to a painful conclusion: ...

Prior to starting his own business, Mark served as the Technical Editor on EC&M for six years, worked three years in nuclear ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...

Discover the top 3 undervalued Hotels, Restaurants & Leisure stocks for Wednesday, January 07 based on AAII’s Stock Grades.

MIchaelAaron Flicker is the co-author of "Hacking The Human Mind: The Behavioral Science Secrets Behind 17 of the World's ...

Don Chahbazpour of National Grid explains how biogas and renewable natural gas cut methane, decarbonise gas networks and help ...

Giving glove materials a verifiable “memory” to support safe recovery, traceability, and circular reuse NEW YORK, NY / ACCESS Newswire / December 31, 2025 / SMX (Security Matters) PLC (NASDAQ:SMX; ...